Ihāpera Esson, Susan McAllister, Amy Jones, Darelle Toki, Nina Scott, Philip C Hill
{"title":"Māori notified with tuberculosis in one public health region of Aotearoa New Zealand: a document review.","authors":"Ihāpera Esson, Susan McAllister, Amy Jones, Darelle Toki, Nina Scott, Philip C Hill","doi":"10.26635/6965.7457","DOIUrl":"https://doi.org/10.26635/6965.7457","url":null,"abstract":"<p><strong>Aim: </strong>Among Aotearoa New Zealand-born people with tuberculosis (TB), half are Māori. TB is preventable, and Aotearoa New Zealand has signed up to the global strategy to end the TB epidemic. TB among Māori has endured since the late 1800s and occurs in a complex political, social and wellbeing context. We aimed to review current public health practices used for contacting and following up Māori with TB and their contacts.</p><p><strong>Methods: </strong>We undertook a retrospective case review of Māori notified with pulmonary TB (2018- 2023) in the Waikato Region. Data included TB notification, treatment start and end dates, number and type of contacts, latent TB infection (LTBI) testing, screening and support for wellbeing issues.</p><p><strong>Results: </strong>Seventeen Māori were identified with pulmonary TB (aged 23-81 years). Sixteen started and 13 completed treatment. One died prior to formal TB notification; two died during treatment. A total of 182 contacts were identified-mostly household contacts (42%) and hospital staff (25%). Sixty-four percent (n=117) of contacts were screened for LTBI: 15 (11%) tested positive and were referred for follow-up. Health navigator support was noted for two patients only.</p><p><strong>Conclusion: </strong>A new model of care is required for contacting and following up Māori with TB and their contacts to end the Māori TB epidemic.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"51-61"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Is self-efficacy after spinal cord injury associated with hospital re-admissions or length of stay in Aotearoa New Zealand? A cross-sectional analysis.","authors":"Bensy Mathew, Mitchell Wolden, Rachelle Martin","doi":"10.26635/6965.7412","DOIUrl":"https://doi.org/10.26635/6965.7412","url":null,"abstract":"<p><strong>Aim: </strong>The transition from inpatient care to the community challenges coping strategies in spinal cord injury (SCI), and acute hospital re-admissions may act as profound psychological disruptors. This study compared self-efficacy scores between discharge and 18-month follow-up and examined the association of self-efficacy with hospital re-admissions and length of stay (LOS).</p><p><strong>Methods: </strong>This repeated cross-sectional study utilised New Zealand Spinal Cord Injury Registry data. One hundred and one participants (35.3% response rate) provided general self-efficacy (GSE) scores at discharge and 18 months. Analysis included paired t-tests, a one-way analysis of covariance comparing readmission groups (controlling for baseline GSE), and linear regression assessing log-transformed LOS.</p><p><strong>Results: </strong>GSE scores declined significantly from a mean of 34.1 at discharge to 32.2 at 18 months (p=0.0001; Cohen's d=0.4). After adjusting for baseline scores, participants with hospital re-admissions had significantly lower GSE at 18 months (M=31.0) than those without (M=32.9; p=0.036; adjusted Cohen's d=0.43). LOS did not show an association with GSE scores (p=0.778).</p><p><strong>Conclusion: </strong>Self-efficacy significantly erodes during the transition from rehabilitation to community dwelling. Hospital re-admissions appear to have a significant association with lower self-efficacy at 18 months even when accounting for baseline self-efficacy levels.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"32-41"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Porta hepatis schwannoma: case report of a rare benign neoplasm in a patient with chronic hepatitis B.","authors":"Jonathan J Sheu, Judy C Huang, Adam Sr Bartlett","doi":"10.26635/6965.7565","DOIUrl":"https://doi.org/10.26635/6965.7565","url":null,"abstract":"","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"82-85"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Longer-term outcomes of intravitreal therapy for neovascular age-related macular degeneration at a peripheral centre (Palmerston North eye clinic).","authors":"Brandon Nunns, Aqeeda Singh, John Ah-Chan","doi":"10.26635/6965.7545","DOIUrl":"https://doi.org/10.26635/6965.7545","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study was to evaluate long-term real-world outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration (nAMD) at a regional New Zealand centre, with a primary focus on treatment duration and reasons for cessation.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted at Palmerston North eye clinic, including all newly diagnosed eyes with nAMD initiating anti-VEGF therapy between November 2017 and August 2023. Demographic data, visual acuity, treatment duration and documented reasons for cessation were extracted from a prospectively maintained database and validated against electronic health records.</p><p><strong>Results: </strong>Among 527 eyes from 446 patients, 39.8% ceased treatment. The most common reasons were end-stage disease (44.8%), patient death (21.9%), logistical factors (17.6%) and injection intolerance (8.1%). Mean treatment duration was 421 days. Visual outcomes were favourable overall with 20.2% of eyes improving and 59.5% remaining stable. Better baseline visual acuity strongly predicted better final vision.</p><p><strong>Conclusions: </strong>High early cessation due to end-stage disease suggests possible late presentation, underscoring the need for earlier detection and referral. Addressing logistical barriers and supporting adherence will be increasingly important as demand for anti-VEGF therapy grows with an ageing population.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"24-31"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Desmond Lim, Fouzia Ziad, James Cleland, Peter Wright
{"title":"Sporadic late-onset nemaline myopathy associated with monoclonal gammopathy: a case report with review of literature.","authors":"Desmond Lim, Fouzia Ziad, James Cleland, Peter Wright","doi":"10.26635/6965.7479","DOIUrl":"https://doi.org/10.26635/6965.7479","url":null,"abstract":"","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"86-89"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effectiveness of selective laser trabeculoplasty for glaucoma and ocular hypertension in a large real-world cohort in New Zealand.","authors":"Patchara Jirapanyayut, William Shew, John Ah-Chan","doi":"10.26635/6965.7450","DOIUrl":"https://doi.org/10.26635/6965.7450","url":null,"abstract":"<p><strong>Aim: </strong>The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial supports selective laser trabeculoplasty (SLT) as first-line glaucoma treatment; however, local real-world data are limited. We evaluated the real-world outcomes of SLT on intraocular pressure (IOP) and medication burden in a regional Aotearoa New Zealand hospital.</p><p><strong>Methods: </strong>We conducted a retrospective clinical audit of all SLT procedures performed at Palmerston North Hospital between August 2022 and April 2025. The primary outcome was IOP at final follow-up. The secondary outcome was a change in medication burden. Sub-groups analysed included optimal treatment (360-degree laser, Goldmann applanation tonometry, ≥6 months follow-up) and treatment-naive eyes.</p><p><strong>Results: </strong>A total of 236 eyes from 166 patients were included in the study. Most eyes (93.2%) were on established topical therapy at baseline. Mean IOP reduced from 18.3±5.2mmHg to 14.5±4.2mmHg, a mean reduction of 3.8mmHg (20.8%, p<0.001), with 93.6% achieving IOP ≤21mmHg at final follow-up. The medication burden remained statistically stable. In the optimal sub-group (n=62), 43.5% achieved clinical success (≥20% IOP reduction) with a 3.2mmHg mean drop. In treatment-naive eyes (n=16), mean IOP reduced by 5.3mmHg, with 93.8% remaining drop-free. Baseline IOP was the only significant predictor of clinical success.</p><p><strong>Conclusion: </strong>SLT effectively lowers IOP in a real-world regional New Zealand setting, including in heavily medicated eyes. Stable medication burden reflects adjunctive use in this cohort rather than a procedural limitation. Treatment-naive outcomes support the growing evidence for SLT as a primary intervention.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"42-50"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gerhard Sundborn, Simon Thornley, Bodo Lang, Loma Veatupu
{"title":"A call to all parties: protect our children-regulate sugary drinks in schools.","authors":"Gerhard Sundborn, Simon Thornley, Bodo Lang, Loma Veatupu","doi":"10.26635/6965.7679","DOIUrl":"https://doi.org/10.26635/6965.7679","url":null,"abstract":"","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"90-92"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A retrospective observational study of on-call hospital pharmacist activities in a rural setting in Aotearoa New Zealand.","authors":"Lisa Kremer, Brianna Fisk, Simone Hutchinson, Susannah Rice, Caitlin Wade, Carolyn Coulter","doi":"10.26635/6965.7198","DOIUrl":"10.26635/6965.7198","url":null,"abstract":"<p><strong>Aim: </strong>There is a paucity of published information on pharmacist on-call activities. Rural healthcare settings have been largely overlooked in previous research, which to date focusses on international urban tertiary hospitals. This study's aim is to investigate the types of enquiries, frequency of callbacks, and activities of on-call pharmacists at Timaru Hospital, a rural secondary hospital in Aotearoa New Zealand.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of data entered by on-call pharmacists at Timaru Hospital between January 2021 and December 2023. Data were classified according to enquiry classification, reason for callback, call topic, caller identity, pharmacist level of experience, high-risk APINCH and patient safety.</p><p><strong>Results: </strong>There were 669 enquiries over the 3-year period, at a rate of one phone enquiry every 1.6 days, and 388 (58%) required a callback. Of the 669 enquiries, 140 (21%) related to high-risk medicines coded to APINCH and 46 (7%) related to patient safety. The on-call service cost approximately NZ$215,150 to NZ$265,850 for the 3 years.</p><p><strong>Conclusion: </strong>Rural hospital on-call pharmacists require general specialist knowledge and broad expertise to be able to respond to the diversity of enquiries relating to medicines information and medication dosing. The results demonstrate the importance and impact of rural hospital pharmacist on-call activities, and the need for improved training and optimised after-hours medicine management.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"62-74"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Angad Vraich, Ella Nicholas, Andrew McCombie, Tim Eglinton, Tamara Glyn
{"title":"Contemporary outcomes and restorative pathways following colectomy for inflammatory bowel disease: a tertiary centre cohort from Aotearoa New Zealand.","authors":"Angad Vraich, Ella Nicholas, Andrew McCombie, Tim Eglinton, Tamara Glyn","doi":"10.26635/6965.7513","DOIUrl":"https://doi.org/10.26635/6965.7513","url":null,"abstract":"<p><strong>Aims: </strong>The aim of this study was to determine 30-day mortality and morbidity following colectomy for inflammatory bowel disease (IBD) at a tertiary New Zealand centre and to establish rectal stump-related outcomes and rates of restoration for intestinal continuity.</p><p><strong>Methods: </strong>A retrospective cohort study of all colectomies performed for IBD at Christchurch Hospital between 1 January 2019 and 31 December 2023 was conducted. Demographic, operative and outcome data were extracted from patient records. Descriptive statistics and univariate analyses were performed.</p><p><strong>Results: </strong>Fifty patients were included (31 ulcerative colitis, 17 Crohn's disease, two indeterminate colitis). There were no 30-day deaths. Sixty-four percent of patients experienced at least one complication. Open surgery was associated with significantly higher rates of major complications compared with laparoscopic surgery (odds ratio 5.1, p=0.02). Complication rates varied between rectal stump management strategies, although sub-group numbers were small. Among patients potentially eligible for restoration, 26% underwent ileal pouch formation; patient preference was the most cited reason for not proceeding.</p><p><strong>Conclusions: </strong>Contemporary colectomy for IBD in this cohort was associated with zero short-term mortality and acceptable morbidity. Laparoscopic surgery was associated with fewer major complications, although selection bias cannot be excluded. Given small sample size, findings regarding rectal stump management should be cautiously interpreted. Restorative surgery occurred in a minority, reinforcing need for clear restorative pathways and longitudinal specialist follow-up.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"15-23"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Election 2026 and health: promises, priorities and delivery.","authors":"Frank Frizelle","doi":"10.26635/6965.e1643","DOIUrl":"https://doi.org/10.26635/6965.e1643","url":null,"abstract":"","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1643","pages":"9-14"},"PeriodicalIF":1.2,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}